Skip to main content

Please note that this is a beta version of our website. Should you encounter any bugs, glitches, lack of functionality or other problems on the website, please let us know immediately so we can rectify these accordingly. Your help in this regard is greatly appreciated! You can email us.

Login to North West London Pathology – consumables service

If you need a new account or you have a query about your order, please telephone the pathology call centre on 0203 313 5353.

If you have forgotten your password you can reset this yourself. Please click here if you have forgotten your password.

Results Line and Enquiries

0203 313 5353

Drugs of Abuse Screen (Urine)

Category Biochemistry
Test background

Drugs of abuse testing in urine, is provided on a non-urgent basis by the laboratory for the most commonly requested compounds: amphetamines, benzodiazepines, cannabinoids, cocaine, opiates and methadone (EDDP, a metabolite for methadone is also tested). The majority of samples received are for monitoring compliance with treatment replacement or abstention in the community setting.

The initial screening assay and the confirmation report qualitative results. Cut offs for all tests are based on the European Workplace Testing Guidelines (EWTG).

The screening tests for opiates and amphetamines are not specific for drugs of abuse and can give positive results in patients who have taken over the counter or prescribed medications. Gas chromatography-mass spectrometry is used to confirm positive screening results for opiates and amphetamines.

Clinicial Indications

The test may be requested to identify illicit drug abuse, intentional or inadvertent ingestion of prescription or over-the-counter medication.

Sample & container required Random urine in universal container
Sample volume 5ml
Notes

Routine profile includes opiates, amphetamines, methadone, methadone metabolite, cocaine, cannabis and benzodiazepines.

Samples Positive for Amphetamines and/or opiates are confirmed by GCMS.